Determinants of treatment satisfaction among patients with diabetes: multicentre cross-sectional study in Northwest Ethiopia.

Diabetes & endocrinology General diabetes Patient Satisfaction Quality in health care

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
04 09 2023
Historique:
medline: 6 9 2023
pubmed: 5 9 2023
entrez: 4 9 2023
Statut: epublish

Résumé

Treatment satisfaction is a significant determinant of quality of care, especially for patients with chronic diseases such as diabetes. Identifying factors that contribute to treatment satisfaction may improve patient outcomes. This study examined treatment satisfaction and determinant factors in patients with diabetes. A multicentre hospital-based cross-sectional study was conducted between April and July 2022 at selected hospitals in Northwest Ethiopia. Eligible adult patients with diabetes were included in the study. Treatment satisfaction was the main outcome and was measured using the Diabetes Treatment Satisfaction Questionnaire, which was valid and reliable in the current sample. A linear regression analysis was used to determine the association between treatment satisfaction scores and independent variables. Out of the 422 patients approached, 402 (95.3%) participated in the study. Overall, the mean treatment satisfaction score was 17.13 (±3.3) out of 30. Most of the participants had a lower degree of satisfaction with the current treatment (>52%) and its convenience (>63%). More than half of the participants (51.2%) perceived hyperglycaemia most of the time and hypoglycaemia some of the time (64.9%). Treatment satisfaction was influenced by body mass index (BMI) (p<0.01), number of medical conditions and medications (p<0.001), hyperglycaemia perception (p<0.001), healthcare cost coverage (p<0.001), monthly salary (p<0.001), self-monitoring blood glucose (SMBG) (p=0.017), lifestyle modification status (p<0.01), and comorbidity and/or complications (p<0.001). Treatment satisfaction was low among patients with a higher BMI, a higher number of medical conditions and medications, comorbidities and/or complications, a frequent perception of hyperglycaemia and a lower monthly salary. Interventions addressing specific independent variables might enhance treatment satisfaction.

Identifiants

pubmed: 37666554
pii: bmjopen-2023-074731
doi: 10.1136/bmjopen-2023-074731
pmc: PMC10481752
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e074731

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Diabet Med. 1994 Jun;11(5):510-6
pubmed: 8088133
World J Diabetes. 2017 Apr 15;8(4):120-129
pubmed: 28465788
JAMA. 2002 Sep 25;288(12):1484-90
pubmed: 12243635
Endocr J. 2018 Oct 29;65(10):1001-1009
pubmed: 30033945
Semergen. 2016 Jul-Aug;42(5):298-306
pubmed: 26188491
Fam Pract. 2009 Apr;26(2):102-8
pubmed: 19254969
Transl Pediatr. 2017 Oct;6(4):383-396
pubmed: 29184819
PLoS One. 2022 Sep 21;17(9):e0274971
pubmed: 36130160
J Multidiscip Healthc. 2020 Dec 02;13:1817-1826
pubmed: 33293824
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
Diabetes Care. 2018 Feb;41(2):267-276
pubmed: 29183910
BMC Public Health. 2014 Jun 11;14:591
pubmed: 24920538
PLoS One. 2022 May 26;17(5):e0268639
pubmed: 35617250
Saudi Pharm J. 2012 Oct;20(4):323-30
pubmed: 23960807
BMJ Open. 2017 Jul 11;7(7):e016180
pubmed: 28701411
Bol Asoc Med P R. ;108(1):57-62
pubmed: 29193919
Health Qual Life Outcomes. 2010 Jul 13;8:67
pubmed: 20626879
Niger J Clin Pract. 2014 Mar-Apr;17(2):218-25
pubmed: 24553035
Int J Clin Exp Med. 2014 Dec 15;7(12):5715-22
pubmed: 25664097
PLoS One. 2022 Feb 18;17(2):e0264199
pubmed: 35180266
Diabet Med. 1990 Jun;7(5):445-51
pubmed: 2142043
Int J Environ Res Public Health. 2018 May 09;15(5):
pubmed: 29747423
Nutr Metab Cardiovasc Dis. 2009 Jan;19(1):45-53
pubmed: 18450436
Diabetes Res Clin Pract. 2017 Jun;128:40-50
pubmed: 28437734
Diabetol Metab Syndr. 2021 May 19;13(1):55
pubmed: 34011388
Endocrinol Nutr. 2014 Jan;61(1):18-26
pubmed: 24055176
PLoS One. 2019 Oct 1;14(10):e0222985
pubmed: 31574113
Rev Assoc Med Bras (1992). 2014 Jan-Feb;60(1):59-62
pubmed: 24918854
Empl Benefits J. 1997 Mar;22(1):12-5
pubmed: 10165682

Auteurs

Ashenafi Kibret Sendekie (AK)

Departiment of Clinical Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia ashukib02@yahoo.com.

Eyayaw Ashete Belachew (EA)

Departiment of Clinical Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Ephrem Mebratu Dagnew (EM)

Departiment of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH